Works matching IS 1619-7070 AND VI 49 AND IP 13 AND DT 2022

Results: 39
    1
    2
    3

    Hetero-bivalent agents targeting FAP and PSMA.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4369, doi. 10.1007/s00259-022-05933-3
    By:
    • Boinapally, Srikanth;
    • Lisok, Alla;
    • Lofland, Gabriela;
    • Minn, Il;
    • Yan, Yu;
    • Jiang, Zirui;
    • Shin, Min Jay;
    • Merino, Vanessa F.;
    • Zheng, Lei;
    • Brayton, Cory;
    • Pomper, Martin G.;
    • Banerjee, Sangeeta Ray
    Publication type:
    Article
    4
    5

    [<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4736, doi. 10.1007/s00259-022-05925-3
    By:
    • Rosar, Florian;
    • Schaefer-Schuler, Andrea;
    • Bartholomä, Mark;
    • Maus, Stephan;
    • Petto, Sven;
    • Burgard, Caroline;
    • Privé, Bastiaan M.;
    • Franssen, Gerben M.;
    • Derks, Yvonne H. W.;
    • Nagarajah, James;
    • Khreish, Fadi;
    • Ezziddin, Samer
    Publication type:
    Article
    6
    7
    8

    Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4716, doi. 10.1007/s00259-022-05920-8
    By:
    • Öcal, Osman;
    • Schütte, Kerstin;
    • Zech, Christoph J.;
    • Loewe, Christian;
    • van Delden, Otto;
    • Vandecaveye, Vincent;
    • Verslype, Chris;
    • Gebauer, Bernhard;
    • Sengel, Christian;
    • Bargellini, Irene;
    • Iezzi, Roberto;
    • Philipp, Alexander;
    • Berg, Thomas;
    • Klümpen, Heinz J.;
    • Benckert, Julia;
    • Pech, Maciej;
    • Gasbarrini, Antonio;
    • Amthauer, Holger;
    • Bartenstein, Peter;
    • Sangro, Bruno
    Publication type:
    Article
    9

    EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4652, doi. 10.1007/s00259-022-05919-1
    By:
    • van Sluis, Joyce;
    • van Snick, Johannes H.;
    • Brouwers, Adrienne H.;
    • Noordzij, Walter;
    • Dierckx, Rudi A. J. O.;
    • Borra, Ronald J. H.;
    • Slart, Riemer H. J. A.;
    • Lammertsma, Adriaan A.;
    • Glaudemans, Andor W. J. M.;
    • Boellaard, Ronald;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    10
    11
    12
    13

    Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4589, doi. 10.1007/s00259-022-05915-5
    By:
    • Cuberas-Borrós, Gemma;
    • Roca, Isabel;
    • Castell-Conesa, Joan;
    • Núñez, Laura;
    • Boada, Mercè;
    • López, Oscar L.;
    • Grifols, Carlota;
    • Barceló, Miquel;
    • Pareto, Deborah;
    • Páez, Antonio
    Publication type:
    Article
    14
    15
    16

    Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [<sup>18</sup>F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4677, doi. 10.1007/s00259-022-05917-3
    By:
    • Henriksen, Otto M.;
    • Hansen, Adam E.;
    • Muhic, Aida;
    • Marner, Lisbeth;
    • Madsen, Karine;
    • Møller, Søren;
    • Hasselbalch, Benedikte;
    • Lundemann, Michael J.;
    • Scheie, David;
    • Skjøth-Rasmussen, Jane;
    • Poulsen, Hans S.;
    • Larsen, Vibeke A.;
    • Larsson, Henrik B. W.;
    • Law, Ian
    Publication type:
    Article
    17

    Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4642, doi. 10.1007/s00259-022-05916-4
    By:
    • Eertink, Jakoba J.;
    • Zwezerijnen, Gerben J. C.;
    • Cysouw, Matthijs C. F.;
    • Wiegers, Sanne E.;
    • Pfaehler, Elisabeth A. G.;
    • Lugtenburg, Pieternella J.;
    • van der Holt, Bronno;
    • Hoekstra, Otto S.;
    • de Vet, Henrica C. W.;
    • Zijlstra, Josée M.;
    • Boellaard, Ronald
    Publication type:
    Article
    18
    19
    20

    Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [<sup>18</sup>F]FDG PET/CT imaging: quantitative analysis of [<sup>18</sup>F]FDG uptake in primary tumors and metastatic lymph nodes.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4692, doi. 10.1007/s00259-022-05904-8
    By:
    • Wang, DaQuan;
    • Zhang, Xu;
    • Liu, Hui;
    • Qiu, Bo;
    • Liu, SongRan;
    • Zheng, ChaoJie;
    • Fu, Jia;
    • Mo, YiWen;
    • Chen, NaiBin;
    • Zhou, Rui;
    • Chu, Chu;
    • Liu, FangJie;
    • Guo, JinYu;
    • Zhou, Yin;
    • Zhou, Yun;
    • Fan, Wei
    Publication type:
    Article
    21

    Pilot study of a novel nanobody <sup>68</sup> Ga-NODAGA-SNA006 for instant PET imaging of CD8<sup>+</sup> T cells.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4394, doi. 10.1007/s00259-022-05903-9
    By:
    • Wang, Yan;
    • Wang, Chao;
    • Huang, Minzhou;
    • Qin, Songbing;
    • Zhao, Jun;
    • Sang, Shibiao;
    • Zheng, Meng;
    • Bian, Yicong;
    • Huang, Chenrong;
    • Zhang, Hua;
    • Guo, Lingchuan;
    • Jiang, Jiwei;
    • Xu, Chun;
    • Dai, Na;
    • Zheng, Yushuang;
    • Han, Jiajun;
    • Yang, Min;
    • Xu, Tao;
    • Miao, Liyan
    Publication type:
    Article
    22

    Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4705, doi. 10.1007/s00259-022-05902-w
    By:
    • Roosen, Joey;
    • Westlund Gotby, Lovisa E. L.;
    • Arntz, Mark J.;
    • Fütterer, Jurgen J.;
    • Janssen, Marcel J. R.;
    • Konijnenberg, Mark W.;
    • van Wijk, Meike W. M.;
    • Overduin, Christiaan G.;
    • Nijsen, J. Frank W.
    Publication type:
    Article
    23

    Artificial intelligence guided enhancement of digital PET: scans as fast as CT?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4503, doi. 10.1007/s00259-022-05901-x
    By:
    • Hosch, René;
    • Weber, Manuel;
    • Sraieb, Miriam;
    • Flaschel, Nils;
    • Haubold, Johannes;
    • Kim, Moon-Sung;
    • Umutlu, Lale;
    • Kleesiek, Jens;
    • Herrmann, Ken;
    • Nensa, Felix;
    • Rischpler, Christoph;
    • Koitka, Sven;
    • Seifert, Robert;
    • Kersting, David
    Publication type:
    Article
    24

    Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4551, doi. 10.1007/s00259-022-05899-2
    By:
    • Pitombeira, Milena Sales;
    • Koole, Michel;
    • Campanholo, Kenia R.;
    • Souza, Aline M.;
    • Duran, Fábio L. S.;
    • Solla, Davi J. Fontoura;
    • Mendes, Maria F.;
    • Pereira, Samira L. Apóstolos;
    • Rimkus, Carolina M.;
    • Busatto, Geraldo Filho;
    • Callegaro, Dagoberto;
    • Buchpiguel, Carlos A.;
    • de Paula Faria, Daniele
    Publication type:
    Article
    25
    26

    Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4567, doi. 10.1007/s00259-022-05897-4
    By:
    • Salvadó, Gemma;
    • Milà-Alomà, Marta;
    • Shekari, Mahnaz;
    • Ashton, Nicholas J.;
    • Operto, Grégory;
    • Falcon, Carles;
    • Cacciaglia, Raffaele;
    • Minguillon, Carolina;
    • Fauria, Karine;
    • Niñerola-Baizán, Aida;
    • Perissinotti, Andrés;
    • Benedet, Andréa L.;
    • Kollmorgen, Gwendlyn;
    • Suridjan, Ivonne;
    • Wild, Norbert;
    • Molinuevo, José Luis;
    • Zetterberg, Henrik;
    • Blennow, Kaj;
    • Suárez-Calvet, Marc;
    • Gispert, Juan Domingo
    Publication type:
    Article
    27

    X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer's disease.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4338, doi. 10.1007/s00259-022-05896-5
    By:
    • Barbone, Giacomo E.;
    • Bravin, Alberto;
    • Mittone, Alberto;
    • Pacureanu, Alexandra;
    • Mascio, Giada;
    • Di Pietro, Paola;
    • Kraiger, Markus J.;
    • Eckermann, Marina;
    • Romano, Mariele;
    • Hrabě de Angelis, Martin;
    • Cloetens, Peter;
    • Bruno, Valeria;
    • Battaglia, Giuseppe;
    • Coan, Paola
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4382, doi. 10.1007/s00259-022-05888-5
    By:
    • Fu, Yingli;
    • Yu, Jing;
    • Liatsou, Ioanna;
    • Du, Yong;
    • Josefsson, Anders;
    • Nedrow, Jessie R.;
    • Rindt, Hans;
    • Bryan, Jeffrey N.;
    • Kraitchman, Dara L.;
    • Sgouros, George
    Publication type:
    Article
    34
    35
    36
    37
    38
    39